| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Healthia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.56 |
| 52 Week High | AU$0.92 |
| 52 Week Low | AU$0.49 |
| Beta | 1.08 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -28.93% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -57.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| HE3 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | -1.8% |
| 1Y | -28.9% | 24.7% | 13.6% |
Return vs Industry: HE3 underperformed the German Healthcare industry which returned 10.6% over the past year.
Return vs Market: HE3 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| HE3 volatility | |
|---|---|
| HE3 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HE3 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HE3's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Wes Coote | www.healthia.com.au |
Healthia Limited provides health services in Australia. It operates through three segments: Feet & Ankles; Bodies & Minds; and Eyes & Ears. The company operates podiatry and retail footwear; physiotherapy, hand therapy, occupational therapy, exercise physiology, and speech pathology clinics; and optometry and audiology stores, as well as manufactures and sells orthotic devices.
Healthia Limited Fundamentals Summary
| HE3 fundamental statistics | |
|---|---|
| Market cap | €151.75m |
| Earnings (TTM) | €3.29m |
| Revenue (TTM) | €152.05m |
46.0x
P/E Ratio1.0x
P/S RatioIs HE3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HE3 income statement (TTM) | |
|---|---|
| Revenue | AU$252.56m |
| Cost of Revenue | AU$175.80m |
| Gross Profit | AU$76.75m |
| Other Expenses | AU$71.29m |
| Earnings | AU$5.47m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.039 |
| Gross Margin | 30.39% |
| Net Profit Margin | 2.16% |
| Debt/Equity Ratio | 50.7% |
How did HE3 perform over the long term?
See historical performance and comparison